Respiratory Medicine and Research

Papers
(The TQCC of Respiratory Medicine and Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease10
Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges9
One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity8
Proposals from a French expert panel for respiratory care in ALS patients8
Delayed pulmonary abscess following COVID-19 pneumonia: A case report8
Nebulization: A potential source of SARS-CoV-2 transmission7
Severe SARS-CoV-2 pneumonia: Clinical, functional and imaging outcomes at 4 months7
Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center6
Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment 6
Temporal evolution of diaphragm thickness and diaphragm excursion among subjects hospitalized with COVID-19: A prospective observational study6
Phenotyping to Target Obstructive Sleep Apnoea Syndrom (OSAS) in adults patients with severe asthma5
Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study5
Prognostic value of lung ultrasound and its link with inflammatory biomarkers in patients with SARS-CoV-2 infection5
One-minute sit-to-stand test as an alternative tool to assess the quadriceps muscle strength in children5
Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study5
Eosinophilic vasculitis associated with persistent dupilumab-induced hypereosinophilia in severe asthma5
Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study4
Study protocol to assess polypharmacy and comorbidities in lung cancer4
Pneumonia severity indices predict prognosis in coronavirus disease-20194
Paediatric aspects of COVID-19: An update4
Bronchoscopy use in the COVID-19 era4
Alveolar lymphocytosis with plasmacytosis in severe COVID-194
The 3 Minute Step Test is a validated field test to evaluate the functional exercise capacity in children aged 6 to 124
Blood urea nitrogen to albumin ratio as a predictive factor for pneumonia: A meta-analysis4
Effects of elexacaftor–tezacaftor–ivacaftor discontinuation in cystic fibrosis4
The determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohort4
Prevalence and outcome of steroid-resistant/refractory pneumonitis induced by immune checkpoint inhibitors4
Pulmonary embolism among critically ill patients with ARDS due to COVID-193
Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience3
Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital3
Altitude healing effect in severe asthmatic children3
Self-reported asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey3
Asthma and smoking: A review3
MicroRNA-4732 is downregulated in non-small cell lung cancer and inhibits tumor cell proliferation, migration, and invasion3
Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases3
Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: A systematic review3
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version3
CT features of community-acquired pneumonia at the emergency department3
Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience3
French recommendations for the diagnosis and management of lymphangioleiomyomatosis3
Effect of exercise-based pulmonary rehabilitation in patients with bronchiectasis: A meta-analysis3
SPLF/SMFU/SRLF/SFAR/SFCTCV Guidelines for the management of patients with primary spontaneous pneumothorax3
Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective3
Objective structured clinical examinations (OSCEs) for students’ training and assessment in the French respiratory medicine departments in 2021: An overview2
Covid-19 severe hypoxemic pneumonia: A clinical experience using high-flow nasal oxygen therapy as first-line management2
PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitors2
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy2
Effects of pulmonary rehabilitation on fear of falling in Chronic Obstructive Pulmonary Disease (COPD) patients: An observational study2
Psychiatric disorders and long COVID2
Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in Obstructive Sleep Apnea Patients Treated with Positive Airway Pressure2
Cardiovascular manifestations secondary to COVID-19: A narrative review2
Immunosuppression in a lung transplant recipient with COVID-19? Lessons from an early case2
Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol2
Coping strategies, anxiety and depression related to the COVID-19 pandemic in lung transplant candidates and recipients. Results from a monocenter series2
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy2
Progression to a severe form of COVID-19 among patients with chronic respiratory diseases2
Self-expanding metallic Y-stent compared to silicone Y-stent for malignant lesions of the main carina: A single center retrospective study2
Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short ver2
Risk assessment tools for survival prognosis: An era of new surrogacy endpoints for clinical outcome measurement in pulmonary arterial hypertension clinical trials?2
Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort2
Screening for impaired pulmonary function using peak expiratory flow: Performance of different interpretation strategies2
Effects of assist parameter on the performance of proportional assist ventilation in a lung model of chronic obstructive pulmonary disease2
Prevalence, predicting factors and impact of internet use by patients with idiopathic pulmonary fibrosis: A cross-sectional observational study2
Lung transplantation in the COVID-19 Era: A multi-faceted challenge2
Covid-19: Adapting the geriatric organisations to respond to the pandemic2
Expectations about treatment of idiopathic pulmonary fibrosis: Comparative survey of patients, carers and physicians (the RESPIR French survey)2
Screening for COPD in primary care, involving dentists, pharmacists, physiotherapists, nurses and general practitioners (the UNANIME pilot study)2
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 20222
Sleep apnoea and cancer risk: Where are we now?2
Two-photon microscopy analysis reveals different pulmonary damage after infection by influenza or SARS-CoV-22
Disease stage-related survival in idiopathic pulmonary fibrosis patients treated with nintedanib and pirfenidone: An exploratory study2
Evaluation of reported medical services provided to pediatric viral bronchiolitis diagnoses during the COVID-19 pandemic2
Continuous positive airway pressure treatment for obstructive sleep apnea, hospitalizations, and related costs in the French National Healthcare Insurance database1
Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis1
Impact of pharmacological and non-pharmacological interventions on mortality in chronic obstructive pulmonary disease (COPD) patients1
Venous thromboembolism and COVID-191
COVID-19 spread: The Italian case1
A 52-year-old immunocompromised man with an unusual cause of infectious lung cavitary inducing acute respiratory failure1
Changes in the management of chronic thromboembolic pulmonary hypertension over a 10-year period, in a French expert regional competence centre1
Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases1
Is manual therapy of the diaphragm effective for people with obstructive lung diseases? A systematic review1
Bird ownership and pulmonary outcomes apart from hypersensitivity pneumonitis in European older adults1
Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis1
Comparison of two pregnancies with and without elexacaftor-tezacaftor-ivacaftor in a woman with cystic fibrosis1
Eating fish and fruits are associated with lower prevalence of allergic diseases1
Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials1
Bronchoscopy in times of COVID-19 pandemic: An interventional pulmonology unit experience1
COVID-19 and Pneumocystis jirovecii pneumonia: Back to the basics1
Comparison of ChatGPT version 3.5 & 4 for utility in respiratory medicine education using clinical case scenarios1
Prevalence and determinants of current asthma in Cameroon1
Paradoxical bronchospasm in U.S. military veterans with COPD or asthma at a tertiary VA medical center in Chicago, Illinois1
Malignant solitary fibrous tumor of the pleura: A narrative review of clinical characteristics, diagnosis and therapeutic options1
Dysbiosis and leaky gut in hyper-inflated COPD patients: Have smoking and exercise training any role?1
A national survey of early treatment seeking behavior among those with incident SARS-CoV-2 infection1
A foetus with cystic fibrosis – To treat or not to treat?1
Physical activity and sedentary behaviour in patients admitted with COPD: Associated factors1
Underreporting of patient-reported outcomes in cystic fibrosis randomized controlled trials using CONSORT-PRO and RoB 2.01
Relationship of body mass index on activities of daily living in hospitalized patients with chronic obstructive pulmonary disease1
Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?1
Evaluating response to biologics in severe asthma: Precision or guesstimation?1
The effect of statin therapy on disease-related outcomes in idiopathic pulmonary fibrosis: A systematic review and meta-analysis1
Drug-induced interstitial lung disease: Indictment for apixaban1
Home NIV treatment quality in patients with chronic respiratory failure having participated to the French nationwide telemonitoring experimental program (The TELVENT study)1
Invasive methods for the diagnosis and management of intrathoracic extramedullary hematopoiesis: A literature review1
Real-world utility of a genomic classifier in establishing a diagnosis of newly identified interstitial lung disease1
RFC1 gene intronic repeat expansion and unexplained chronic cough: A pathophysiological conundrum1
Growth of home respiratory equipment from 2006 to 2019 and cost control by health policies1
A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir1
Sampling strategy for bacteriological diagnosis of intrathoracic tuberculosis1
Is COVID-19 pneumonia differentiable from other viral pneumonia on CT scan?1
Sequential or combined immune checkpoint inhibitors and targeted therapy: Navigating uncharted waters1
2022 Update of indications and contraindications for lung transplantation in France1
Optic neuritis in lung adenocarcinoma: A challenging diagnosis1
Efficacy of empiric macrolides versus fluoroquinolones in community-acquired pneumonia associated with atypical bacteria: A meta-analysis1
Combined pulmonary fibrosis and emphysema in alpha-1-antitrypsin deficiency1
Lung transplantation for COVID-19-associated acute respiratory distress syndrome: The first French patient1
Challenging diagnosis of granulomatosis after switching mepolizumab by dupilumab for severe asthma1
Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis1
Risk stratification, prognosis, and survival in a pulmonary arterial hypertension cohort in Latin America. A multicenter study1
Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study1
Proposals for managing patients with thoracic malignancies during COVID-19 pandemic1
Impact of the Covid-19 pandemic and lung transplantation program in France1
Eosinophil recovery in hospitalized COVID-19 patients is associated with lower rates of ICU admission and in-hospital mortality: An observational cohort analysis1
Asthmatics with concordant eosinophilic disease classified according to their serum IgE status1
Amyotrophic lateral sclerosis: A pragmatic update on recommendations for respiratory care1
Effects of long-acting bronchodilators on cardiac autonomic control in COPD1
Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study1
Tolerance's improvement of flexible bronchoscopy by Ericksonian hypnosis: The BREATH study1
Familial pleuroparenchymal fibroelastosis: an entity to be recognized1
“Early” and “delayed” intubation of COVID-19 patients: Different definitions, different populations1
Prolonged facial mask wear is a concern for the development of dysbiotic microbiome1
Lower frequency of SARS-CoV-2-associated severe respiratory infections among adults vaccinated against the 2021/22 season influenza1
Feasibility, safety and effectiveness of remote pulmonary rehabilitation during COVID-19 pandemic1
Adalimumab-induced interstitial pneumonia in patients with inflammatory bowel disease1
EBUS-TBNA for the diagnosis of primary pulmonary artery sarcoma1
Prevalence of a decreased FEV3/FEV6 ratio in symptomatic smokers with preserved lung function1
The association between sleep-related breathing disorders and pre-capillary pulmonary hypertension: A chicken and egg question1
COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib1
Immunoglobulins as a treatment modality for corticosteroid-refractory pemetrexed-induced interstitial lung disease, case report1
Patient-important outcomes in lung transplantation: A systematic review1
Critical asthma exacerbations in children are associated with a distinct inflammatory profile1
0.042397022247314